This site is intended for health professionals only
Tuesday 26 March 2019
Share |

Patients' own cells could be the key to treating Crohn's disease

Researchers at the NIHR Guy's and St Thomas' Biomedical Research Centre (BRC) developed the technique by studying white blood cells taken from patients who have Crohn's disease, and comparing them to cells of healthy people. Their findings allowed cell therapy specialists in the BRC to develop a treatment involving taking patients' cells, and culturing them so that they behave more like cells from healthy people.
 
The research, published in the journal Gastroenterology, shows that this technique is effective in human cells.1 The proposed Tribute Trial will test whether the treatment is safe and effective for treating Crohn's disease.
 
Professor Graham Lord, previously Director of the NIHR Guy's and St Thomas' BRC, led the research. He recently took up a role as Vice-President and Dean of the Faculty of Biology, Medicine and Health at the University of Manchester. He said: "This is the next frontier in cell therapy, as we're going beyond treating the symptoms of Crohn's disease, and trying to reset the immune system to address the condition.
 
"It's a real home-grown treatment in the sense that we started with observing cells and tissues donated by patients at Guy's and St Thomas', have developed a treatment, and are now starting to undertake trials, all at the Trust. It shows how central patients are to research, helping to create a treatment that might help thousands more people."
 
Rachel Sawyer, a communications manager who is 50 and lives in Anerley in south east London, was diagnosed with Crohn's disease in 2000 and treated at Guy's and St Thomas'. 
 
She said: "One of the worst things for me was the unpredictability, particularly around needing the toilet in a hurry. Having Crohn's completely re-routes your daily life and makes it hard to do the normal things most of us take for granted like going out socially or taking public transport. Even now, the fear of it is never really far from my mind.
 
"Another difficult thing is the stigma associated with bowel disease. It's difficult to talk and be open about it, even with family and friends. I found life very isolating and challenging at times -- and that's something so many people with Crohn's experience, regardless of whether they were diagnosed years ago or last month. For people diagnosed young, it can impact on the formative years of their life.
 
"Anything that could help people with Crohn's have the confidence to go out and get back to being the people they were destined to be would be a game-changer."
 
The researchers found that specialised white blood cells called regulatory T cells from Crohn's patients produced less of a gut-specific protein called integrin α4β7 than regulatory T cells from healthy people. Working with the specialists at the NIHR Guy's and St Thomas' BRC's Advanced Therapies Manufacturing Platform, they developed a cell therapy technique based on these findings.
 
This technique involves developing cells from the Crohn's disease patients with a molecule called RAR568, which restores healthy levels of integrin α4β7. The cells are then given back to patients by intravenous infusion.
 
Dr Peter Irving, a Consultant Gastroenterologist and co-author on the paper, said: "While the treatments available for Crohn's disease have increased over recent years, they only work in some patients. In addition, the treatments have potentially serious side effects in some patients. This research paves the way for a trial of using patients' own cells to treat their Crohn's disease and we look forward to offering people the chance to take part in the very near future."
 
Source: NIHR Biomedical Research Centre at Guy's and St Thomas' and King's College London.
 
Reference
  1. Goldberg R. Correction of defective T-regulatory cells from patients with Crohn’s disease by ex vivo ligation of retinoic acid receptor alpha. Gastroenterology,2019; DOI: 10.1053/j.gastro.2019.01.025

Ads by Google